Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers

References

• World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405 - 19; PMID: 19817017
   PubMedGoogle Scholar
• Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26:6266 - 73; http://dx.doi.org/10.1016/j.vaccine.2008.09.056; PMID: 18848855
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34:1329 - 39; http://dx.doi.org/10.1093/ije/dyi206; PMID: 16249217
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Chongsrisawat V, Tangkijvanich P. Problems and prevention of viral hepatitis in Thailand. J Med Assoc Thai 2001; 84:Suppl 1 S18 - 25; PMID: 11529332
   PubMedGoogle Scholar
• Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15:1356 - 61; http://dx.doi.org/10.1046/j.1440-1746.2000.0150121356.x; PMID: 11197043
   PubMed Web of Science ®Google Scholar
• Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ, Poerschke G. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002; 20:3739 - 43; http://dx.doi.org/10.1016/S0264-410X(02)00358-4; PMID: 12399203
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28:730 - 6; http://dx.doi.org/10.1016/j.vaccine.2009.10.074; PMID: 19892043
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO expanded programme on immunization. Global advisory group. Wkly Epidemiol Rec 1992; 3:11 - 6
   Google Scholar
• Heron L, Selnikova O, Moiseieva A, Van Damme P, van der Wielen M, Levie K, et al. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial. Vaccine 2007; 25:2817 - 22; http://dx.doi.org/10.1016/j.vaccine.2006.12.021; PMID: 17276552
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:868 - 70; PMID: 12970620
   PubMedGoogle Scholar
• Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 11:1496 - 502; http://dx.doi.org/10.1111/j.1365-3156.2006.01709.x; PMID: 17002723
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011; 18:369 - 75; http://dx.doi.org/10.1111/j.1365-2893.2010.01312.x; PMID: 20384962
   PubMed Web of Science ®Google Scholar
• Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54:1 - 31; PMID: 15647722
   PubMedGoogle Scholar
• McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200:1390 - 6; http://dx.doi.org/10.1086/606119; PMID: 19785526
   PubMed Web of Science ®Google Scholar
• Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28:126 - 35; http://dx.doi.org/10.1093/epirev/mxj010; PMID: 16782778
   PubMed Web of Science ®Google Scholar
• Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005; 194:163 - 8; http://dx.doi.org/10.1007/s00430-004-0231-4; PMID: 15834754
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Sanpavat S, Pongpunglert W, Chumdermpadetsuk S, Sentrakul P, Vandepapelière P, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 1992; 11:816 - 21; http://dx.doi.org/10.1097/00006454-199210000-00002; PMID: 1408478
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed 1997; 77:F47 - 51; http://dx.doi.org/10.1136/fn.77.1.F47; PMID: 9279183
   PubMed Web of Science ®Google Scholar
• Banatvala JE, Van Damme P. Hepatitis B vaccine—do we need boosters?. J Viral Hepat 2003; 10:1 - 6; http://dx.doi.org/10.1046/j.1365-2893.2003.00400.x; PMID: 12558904
   PubMed Web of Science ®Google Scholar
• Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 2008; 27:881 - 5; http://dx.doi.org/10.1097/INF.0b013e31817702ba; PMID: 18756185
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958 - 64; http://dx.doi.org/10.1016/j.vaccine.2007.06.059; PMID: 17714836
   PubMed Web of Science ®Google Scholar
• Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 2007; 120:e373 - 81; http://dx.doi.org/10.1542/peds.2007-0131; PMID: 17636112
   PubMed Web of Science ®Google Scholar
• Chinchai T, Chirathaworn C, Praianantathavorn K, Theamboonlers A, Hutagalung Y, Bock PH, et al. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 2009; 22:125 - 30; http://dx.doi.org/10.1089/vim.2008.0087; PMID: 19326999
   PubMed Web of Science ®Google Scholar
• Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995; 13:443 - 7; http://dx.doi.org/10.1016/0264-410X(94)00010-K; PMID: 7639012
   PubMed Web of Science ®Google Scholar
• Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KGS, Dörner T, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; 6:741 - 50; http://dx.doi.org/10.1038/nri1886; PMID: 16977339
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53:68 - 75; http://dx.doi.org/10.1093/cid/cir270; PMID: 21653306
   PubMed Web of Science ®Google Scholar
• Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40:1415 - 20; http://dx.doi.org/10.1002/hep.20490; PMID: 15565627
   PubMed Web of Science ®Google Scholar
• Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184:905 - 8; http://dx.doi.org/10.1086/323396; PMID: 11509998
   PubMed Web of Science ®Google Scholar
• Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine 2009; 27:6110 - 5; http://dx.doi.org/10.1016/j.vaccine.2009.08.034; PMID: 19716459
   PubMed Web of Science ®Google Scholar